PIONEERS: PHASE III TRIALS OF A NOVEL IMMUNOTHERAPY TO EVALUATE EFFICACY IN A RANGE OF TUMOR TYPES

Serial Number 77741348
602

Registration Progress

Application Filed
May 20, 2009
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

PIONEERS: PHASE III TRIALS OF A NOVEL IMMUNOTHERAPY TO EVALUATE EFFICACY IN A RANGE OF TUMOR TYPES

Basic Information

Serial Number
77741348
Filing Date
May 20, 2009
Abandonment Date
February 19, 2010
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Mar 17, 2010
Classes
042

Rights Holder

Bristol-Myers Squibb Company

03
Address
345 Park Avenue
New York, NY 10154

Ownership History

Bristol-Myers Squibb Company

Original Applicant
03
New York, NY

Legal Representation

Attorney
Nadine P. Flynn

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

8 events
Date Code Type Description Documents
Mar 17, 2010 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Mar 17, 2010 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Aug 18, 2009 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 18, 2009 CNRT F NON-FINAL ACTION MAILED Loading...
Aug 10, 2009 DOCK D ASSIGNED TO EXAMINER Loading...
May 27, 2009 MPMK O NOTICE OF PSEUDO MARK MAILED Loading...
May 26, 2009 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 23, 2009 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Pseudo Mark
PIONEERS: PHASE THREE TRIALS OF A NOVEL IMMUNOTHERAPY TO EVALUATE EFFICACY IN A RANGE OF TUMOR TYPES

Classification

International Classes
042